NDC 42292-040-01 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-040
- Requested NDC
- 42292-040-01
- Package NDCs from labels
- 42292-040-01, 42292-040-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2025-07-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - Mylan Institutional Inc. | Mylan Institutional Inc. | 2025-07-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42292-040-01 | Levothyroxine Sodium | 1 in 1 BLISTER PACK | TABLET | 1 | 11 | |
| 42292-040-20 | Levothyroxine Sodium | 100 in 1 CARTON | TABLET | 100 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-040-01 | EA - Each | 42292-040 | a1f03f74-f346-4e00-92cb-a347740b7a11 | 1 | 2017-03-06 |
| 42292-040-20 | EA - Each | 42292-040 | bfae7927-4a5f-4b55-8334-f695f1110f95 | 1 | 2017-03-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e0503b8c-7eb7-269e-e053-2995a90a1bca | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e08c2af4-c20a-3176-e053-2a95a90a1aa9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e3d949ce-731b-6dfe-e053-2a95a90a0074 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31b5d54-7536-4290-e053-2a95a90ac235 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f32b4a01-edea-fc85-e053-2995a90ac175 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db998119-a293-3568-e053-2995a90ac47a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dfd5b8-06a5-2728-e053-2995a90a298e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | fa15ac73-f4f6-7a6b-e053-6294a90a4f4e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA076187 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31a35cb-fc54-8872-e053-2a95a90ad8e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31ba297-e042-187a-e053-2a95a90a4861 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31d987d-6836-b4a7-e053-2a95a90a8f7b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86e74e1-0d55-8d0e-e053-6394a90a07bf | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86efc89-f784-c8bb-e053-6294a90a63c9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db9821db-3fe3-d1cf-e053-2a95a90a0252 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da570872-94a1-4852-e053-2995a90aacb6 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da827567-810b-624d-e053-2a95a90a9bde | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86fab39-bbd9-a51c-e053-6294a90accd0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dff641-ced3-bae3-e053-2a95a90a2e29 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| blood sugar | CALC PHOS, CARPINUS BETULUS, FLOS, FERRUM PHOS, KALI PHOS, NAT MUR, NAT SULPH, OLEA EUROPAEA, FLOS, SILICEA, SINAPIS ARVENSIS, FLOS | Siddha Flower Essences, LLC | 90ecd62b-c4bc-4bc4-a409-219929a49edb | 2025-12-31 | Warnings | ETJ7Z6XBU4 |
| throat and voice | CERATOSTIGMA WILLMOTTIANUM, FLOS, FERRUM PHOS, HOTTONIA PALUSTRIS, FLOS, KALI MUR, KALI PHOS, MAG PHOS, MIMULUS GUTTATUS, FLOS, NAT MUR, NAT SULPH, SILICEA | Siddha Flower Essences LLC | 375ef37c-d5de-4762-a569-7304d9882520 | 2025-12-31 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.